FR2992315B1 - DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM - Google Patents

DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM

Info

Publication number
FR2992315B1
FR2992315B1 FR1256010A FR1256010A FR2992315B1 FR 2992315 B1 FR2992315 B1 FR 2992315B1 FR 1256010 A FR1256010 A FR 1256010A FR 1256010 A FR1256010 A FR 1256010A FR 2992315 B1 FR2992315 B1 FR 2992315B1
Authority
FR
France
Prior art keywords
diseases
treatment
nervous system
central nervous
derivatives useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1256010A
Other languages
French (fr)
Other versions
FR2992315A1 (en
Inventor
Isabelle Pouty
Georges Massiot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Pierre Fabre Medicament SA
Original Assignee
Centre National de la Recherche Scientifique CNRS
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Pierre Fabre Medicament SA filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR1256010A priority Critical patent/FR2992315B1/en
Priority to PCT/EP2013/063305 priority patent/WO2014001348A1/en
Publication of FR2992315A1 publication Critical patent/FR2992315A1/en
Application granted granted Critical
Publication of FR2992315B1 publication Critical patent/FR2992315B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1256010A 2012-06-25 2012-06-25 DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM Expired - Fee Related FR2992315B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1256010A FR2992315B1 (en) 2012-06-25 2012-06-25 DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
PCT/EP2013/063305 WO2014001348A1 (en) 2012-06-25 2013-06-25 Alkaloid derivatives of cytisine used in the treatment of diseases of the central nervous system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1256010A FR2992315B1 (en) 2012-06-25 2012-06-25 DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM

Publications (2)

Publication Number Publication Date
FR2992315A1 FR2992315A1 (en) 2013-12-27
FR2992315B1 true FR2992315B1 (en) 2014-08-08

Family

ID=48745913

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1256010A Expired - Fee Related FR2992315B1 (en) 2012-06-25 2012-06-25 DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM

Country Status (2)

Country Link
FR (1) FR2992315B1 (en)
WO (1) WO2014001348A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201602145D0 (en) 2016-02-05 2016-03-23 Achieve Pharma Uk Ltd Salt
DK3454904T3 (en) * 2016-05-13 2023-02-06 Pasteur Institut Inhibition of beta-2-nicotinic acetylcholine receptors to treat pathology in Alzheimer's disease
ES2935204T3 (en) 2016-08-19 2023-03-02 Univ Bristol Cytisine derivatives for addiction treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242916A (en) * 1992-07-07 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US6235734B1 (en) * 1996-10-30 2001-05-22 Pfizer Inc Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy

Also Published As

Publication number Publication date
WO2014001348A1 (en) 2014-01-03
FR2992315A1 (en) 2013-12-27

Similar Documents

Publication Publication Date Title
FR19C1062I2 (en) MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES
LTC2785706I2 (en) SUBSTITUTED 4-PHENYL-PYRIDINES FOR THE TREATMENT OF NK-RECEPTOR-RELATED DISEASES
HK1222552A1 (en) Sobetirome in the treatment of myelination diseases
HK1219964A1 (en) Continuous purification of therapeutic proteins
DK2838539T3 (en) ESTROGENDER DERIVATIVES TO USE IN THE TREATMENT OF NEUROLOGICAL DISORDERS
PL3466425T3 (en) Use of glutarimide derivatives in the treatment of eosinophilic diseases
EP2906295A4 (en) Methods of treating ocular diseases
HK1215173A1 (en) Methods of treating s. aureus-associated diseases
HK1204573A1 (en) Treatment of inflammatory skin disorders
DK3065818T3 (en) DEVICE FOR THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM BY USING SENSOR STIMULATION
ES2627541T8 (en) Methods to treat Parkinson's disease
IL235874A0 (en) Treatment of ocular inflammatory diseases using laquinimod
HK1221190A1 (en) The local treatment of inflammatory ophthalmic diseases
DK3447070T3 (en) COMPOUNDS FOR THE TREATMENT OF THE REMYELINATION BLOCK IN DISEASES RELATED TO THE EXPRESSION OF HERV-W KAPPE PROTEIN
FR2993564B1 (en) IMIDAZOPYRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF DIABETES
ITRM20120530A1 (en) COMPOUNDS FOR USE IN THE TREATMENT OF PARASITIC DISEASES
FR2992315B1 (en) DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
CL2015001520A1 (en) Slurp-1 protein for use in the treatment of eye diseases
CO7020916A2 (en) Therapeutic use of imidazopyridine derivatives
EP3046629A4 (en) Treatment of inflammatory skin disease
DK2694056T3 (en) THERAPEUTIC TREATMENT
PL395469A1 (en) Indolamines derivatives for the treatment of diseases of the central nervous system
FR2973376B1 (en) DERIVATIVES USEFUL IN THE TREATMENT OR PREVENTION OF BONE TUMORS
FR3005577B1 (en) TREATMENT OF BUCCAL INCONFORT
FR3015288B1 (en) USE OF NARATRIPTAN IN THE TREATMENT OF ROSACEA

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

ST Notification of lapse

Effective date: 20170228